Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Biochim Biophys Acta. 2016 Sep 3;1864(12):1667–1677. doi: 10.1016/j.bbapap.2016.08.019

Fig. 4.

Fig. 4

Fluorescence emission spectra of FXR-LBD in the presence of different concentrations of ligands. CDCA, the endogenous ligand of FXR, and GG, an in vitro FXR antagonist, were included in the fluorescence titration studies for comparison.